The Immunotoxicity Management Competence Center featured in a special issue of the Brussels Medical Review

The Immunotoxicity Management Competence Center of the H.U.B. has been featured in a special issue of the Brussels Medical Review.

Written by a multidisciplinary panel and led by Prof. Anne-Pascale Meert together with Dr. Maxime Ilzkovitz and Dr. Louis Wolff, this supplement outlines recommendations for the early detection and management of side effects associated with anti-cancer immunotherapies.

These inflammatory and autoimmune complications, which remain insufficiently recognized by many primary care practitioners, are explored in depth within the new Immunotoxicity Management Competence Center at H.U.B. – Institut Jules Bordet. The center was specifically created to centralize expertise and streamline patients’ care pathways.

This special issue is available online free of charge on the AMUB website.